The global rifaximin API market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic. It has multiple indications and is used in treatment of traveller’s diarrhea caused by E. coli; reduction in risk of overt hepatic encephalopathy recurrence; as well as diarrhea-predominant irritable bowel […]
